Metraipolis › archive › dc_424abcfe0f8e

Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and BMI in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A… — Europe PMC PMID:42504019

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42504019
DOI
10.1002/edm2.70294
License (as archived)
solo-consultazione
Archived
2026-10-18T14:10:35.313Z
SHA-256 of the archived text
c95bfa12c427cde82e46268b53aa88e172748e762f97d3a1157c3e03a2a2dddc
Stable URL of this page
https://metraipolis.com/documento/dc_424abcfe0f8e

How to cite

Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and BMI in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A… — Europe PMC PMID:42504019 — Europe PMC (en), https://europepmc.org/article/MED/42504019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_424abcfe0f8e (Metraipolis archive dc_424abcfe0f8e, sha256 c95bfa12c427cde82e46268b53aa88e172748e762f97d3a1157c3e03a2a2dddc)
BibTeX
@misc{dc424abcfe0f8e,
  title = {Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and BMI in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A… — Europe PMC PMID:42504019},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42504019},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_424abcfe0f8e; sha256 c95bfa12c427cde82e46268b53aa88e172748e762f97d3a1157c3e03a2a2dddc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42504019. Agents can read the archived copy with the MCP tool read_document.